Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kentaro Yoshimatsu
Observed names:
K Yoshimatsu,
KENTARO YOSHIMATSU,
Yoshimatsu Kentaro
Institution:
Eisai (Japan)
Observed institutions:
Japanese Foundation For Cancer Research,
Japan Pharmaceutical Manufacturers Association,
Mercian Corporation (Japan),
Eisai (Japan),
The University of Tokyo
OpenAlex ID:
A5105892127
Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
2014
·
Yuji Yamamoto
, Junji Matsui
, et al.
·
Vascular Cell
·
538
PDF
Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle
1999
·
Takashi Owa
, Hiroshi Yoshino
, et al.
·
Journal of Medicinal Chemistry
·
339
Novel sulfonamides as potential, systemically active antitumor agents
1992
·
Hiroshi Yoshino
, Norihiro Ueda
, et al.
·
Journal of Medicinal Chemistry
·
256
Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells
2004
·
Junji Matsui
, Toshiaki Wakabayashi
, et al.
·
Journal of Biological Chemistry
·
230
PDF
In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
2011
·
Mamiko Miyazaki
, Takaaki Horii
, et al.
·
Antimicrobial Agents and Chemotherapy
·
213
PDF
Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 III. In Vitro and In Vivo Antitumor Activities
2004
·
YOSHIHARU MIZUI
, TAKASHI SAKAI
, et al.
·
The Journal of Antibiotics
·
201
PDF
Cell Cycle Regulation in the G1 Phase: A Promising Target for the Development of New Chemotherapeutic Anticancer Agents
2001
·
Takashi Owa
, Hiroshi Yoshino
, et al.
·
Current Medicinal Chemistry
·
174
Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis
2011
·
Katsura Hata
, Takaaki Horii
, et al.
·
Antimicrobial Agents and Chemotherapy
·
162
Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly
2003
·
Kappei Tsukahara
, Katsura Hata
, et al.
·
Molecular Microbiology
·
135
Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.
2002
·
Yasuhiro Funahashi
, Naoko Hata Sugi
, et al.
·
PubMed
·
123
Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity
2016
·
Tatsuma Ban
, Go R. Sato
, et al.
·
Immunity
·
113
Array-Based Structure and Gene Expression Relationship Study of Antitumor Sulfonamides IncludingN-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide andN-(3-Chloro-7-indolyl)-1,4-benzenedisulfonamide
2002
·
Takashi Owa
, Akira Yokoi
, et al.
·
Journal of Medicinal Chemistry
·
82
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
2021
·
Tatsuma Ban
, Masako Kikuchi
, et al.
·
Nature Communications
·
80
PDF
An Angiogenesis Inhibitor E7820 Shows Broad-Spectrum Tumor Growth Inhibition in a Xenograft Model
2004
·
Taro Semba
, Yasuhiro Funahashi
, et al.
·
Clinical Cancer Research
·
80
PDF
Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis.
2002
·
Akira Yokoi
, Junro Kuromitsu
, et al.
·
PubMed
·
77
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment
2012
·
Yoichi Ozawa
, Kazutomi Kusano
, et al.
·
Cancer Chemotherapy and Pharmacology
·
61
A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors
2000
·
Takashi Owa
, Tatsuo Okauchi
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
59
Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor.
1999
·
Y Funahashi
, T Wakabayashi
, et al.
·
PubMed
·
55
Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives
2010
·
Kazutaka Nakamoto
, Itaru Tsukada
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
49
Schizosaccharomyces pombe och1+ encodes α‐1,6‐mannosyltransferase that is involved in outer chain elongation of N‐linked oligosaccharides
2001
·
Takehiko Yoko-o
, Kappei Tsukahara
, et al.
·
FEBS Letters
·
44
Synthesis and Evaluation of Novel Pyrimido-Acridone, -Phenoxadine, and -Carbazole as Topoisomerase II Inhibitors
2004
·
Junichi Kamata
, Toshimi Okada
, et al.
·
Chemical and Pharmaceutical Bulletin
·
42
PDF
Preferential Binding of E7010 to Murine β3‐Tubulin and Decreased β3‐Tubulin in E7010‐resistant Cell Lines
1998
·
Yasuo Iwamoto
, Kazuto Nishio
, et al.
·
Japanese Journal of Cancer Research
·
37
PDF
M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
2016
·
Yoshimi Ohashi
, Mutsumi Okamura
, et al.
·
Cancer Research
·
33
Luminacins. A Family of Capillary Tube Formation Inhibitors from Streptomyces sp. II. Biological Activities.
2000
·
TOSHIAKI WAKABAYASHI
, RENA KAGEYAMA-KAWASE
, et al.
·
The Journal of Antibiotics
·
32
PDF
Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.
2002
·
Katsuji Nakamura
, Hiroyuki Sugumi
, et al.
·
PubMed
·
29
Show more works
View as search
Works count:
68
Citation count:
3,489
H-index:
27
I10-index:
38
Year
Topic
Type